PDB94 - INITIAL ANTIDIABETIC PHARMACOTHERAPY PRESCRIBED TO PATIENTS WITH NEWLY DIAGNOSED TYPE-2 DIABETES IN A COMMERCIAL HEALTH PLAN IN THE UNITED STATED

Journal article

Open access

Peer reviewed

H.A. Althobaiti, M.Y. Alsheikh, E. Seoane-Vazquez, J. Lewis and L.M. Brown

Value in health, Vol.21, pp.S134-S134

10/2018

Files and links (1)

url

https://doi.org/10.1016/j.jval.2018.09.799View

Published (Version of record) Open

1 Record Views

Title: PDB94 - INITIAL ANTIDIABETIC PHARMACOTHERAPY PRESCRIBED TO PATIENTS WITH NEWLY DIAGNOSED TYPE-2 DIABETES IN A COMMERCIAL HEALTH PLAN IN THE UNITED STATED
Creators - without role: H.A. Althobaiti - Chapman University
M.Y. Alsheikh - Chapman University
E. Seoane-Vazquez - Chapman University
J. Lewis - Chapman University
L.M. Brown
Publication Details: Value in health, Vol.21, pp.S134-S134
Identifiers: 9910481808331
Academic Unit: Taif University
Language: English
Resource Type: Journal article